Overexpression of MEKK3 confers resistance to apoptosis through activation of NFkappaB. (Q34282044)

1 August 2017

title

Overexpression of MEKK3 confers resistance to apoptosis through activation of NFkappaB. (English)

1 reference

1 August 2017

1 reference

1 reference

Ajoy K Samanta

1

1 reference

1 August 2017

Helen J Huang

series ordinal

2

1 reference

1 August 2017

Robert C Bast

series ordinal

3

1 reference

1 August 2017

Warren S-L Liao

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

8 December 2003

1 reference

Journal of Biological Chemistry

1 August 2017

published in

1 reference

1 August 2017

volume

279

1 reference

1 August 2017

issue

9

1 reference

1 August 2017

page(s)

7576-7583

1 reference

Mammalian MAP kinase signalling cascades

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Role of MAP kinase in tumor progression and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB kinase-alpha and IkappaB kinase-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

NAK is an IkappaB kinase-activating kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Mekk3 is essential for early embryonic cardiovascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

The essential role of MEKK3 in TNF-induced NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

NF-kappaB in cancer: a marked target

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

NF-kappaB at the crossroads of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

NF-kappaB as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

The IKK/NF-kappa B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Recent advances in understanding NF-kappaB regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Apoptosis and nuclear factor-kappa B: a tale of association and dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

NF-kappaB in cancer: from innocent bystander to major culprit

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

NF-kappaB activation and inhibition: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Mechanisms of NF-kappaB activation by the HTLV type 1 tax protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Persistent activation of NF-kappa B by the tax transforming protein involves chronic phosphorylation of IkappaB kinase subunits IKKbeta and IKKgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Oncoprotein suppression of tumor necrosis factor-induced NF kappa B activation is independent of Raf-controlled pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Ectopic expression of protein-tyrosine kinase Bcr-Abl suppresses tumor necrosis factor (TNF)-induced NF-kappa B activation and IkappaBalpha phosphorylation. Relationship with down-regulation of TNF receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Nuclear transcription factor-kappaB as a target for cancer drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

GRP94/gp96 elicits ERK activation in murine macrophages. A role for endotoxin contamination in NF-kappa B activation and nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Interleukin-4 down-regulates both forms of tumor necrosis factor receptor and receptor-mediated apoptosis, NF-kappaB, AP-1, and c-Jun N-terminal kinase. Comparison with interleukin-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

PARP is important for genomic stability but dispensable in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

BCL-2 in prostate cancer: a minireview

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Akt is a major downstream target of PI3-kinase involved in angiotensin II-induced proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Map kinase signaling pathways and hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Combined action of ERK and NF kappa B mediates the protective effect of phorbol ester on Fas-induced apoptosis in Jurkat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Synthetic inhibitor of matrix metalloproteases decreases tumor growth and metastases in a syngeneic model of rat prostate cancer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

NIK is a component of the EGF/heregulin receptor signaling complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

Chemotherapeutic drugs--more really is not better

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311659200

21 January 2018

Identifiers

DOI

10.1074/JBC.M311659200

1 reference

1 August 2017

1 reference